[en] The purpose of this study was to develop different injectable nanosized drug delivery systems (NDDSs) i.e. liposome, lipid nanocapsule (LNC) and polymeric nanocapsule (PNC) encapsulating apigenin (AG) and compare their characteristics to identify the nanovector(s) that can deliver the largest quantity of AG while being biocompatible. Two liposomes with different surface characteristics (cationic and anionic), a LNC and a PNC were prepared. A novel tocopherol modified poly(ethylene glycol)-b-polyphosphate block-copolymer was used for the first time for the PNC preparation. The NDDSs were compared by their physicochemical characteristics, AG release, storage stability, stability in serum, complement consumption and toxicity against a human macrovascular endothelial cell line (EAhy926). The diameter and surface charge of the NDDSs were comparable with previously reported injectable nanocarriers. The NDDSs showed good encapsulation efficiency and drug loading. Moreover, the NDDSs were stable during storage and in fetal bovine serum for extended periods, showed low complement consumption and were non-toxic to EAhy926 cells up to high concentrations. Therefore, they can be considered as potential injectable nanocarriers of AG. Due to less pronounced burst effect and extended release characteristics, the nanocapsules could be favorable approaches for achieving prolonged pharmacological activity of AG using injectable NDDS.
Research Center/Unit :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège Center for Education and Research on Macromolecules (CERM) CESAM Complex and Entangled Systems from Atoms to Materials (CESAM)
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Karim, Reatul ; Université de Liège > Département de pharmacie > Pharmacie galénique
Palazzo, Claudio ; Université de Liège > Département de pharmacie > Département de pharmacie
Laloy, Julie; University of Namur > Namur Nanosafety Centre (NNC), Department of Pharmacy
Delvigne, Anne-Sophie; University of Namur > Namur Nanosafety Centre (NNC), Department of Pharmacy
Vanslambrouck, Stéphanie ; University of Liège - ULiège > Complex and Entangled Systems from Atoms to Materials (CESAM), Center for Education and Research on Macromolecules (CERM)
Jérôme, Christine ; University of Liège - ULiège > Complex and Entangled Systems from Atoms to Materials (CESAM), Center for Education and Research on Macromolecules (CERM)
Lepeltier, Elise; University of Angers > MINT, INSERM 1066, CNRS 6021
Orange, Francois; Université Côte d’Azur > Centre Commun de Microscopie Appliquée
Dogne, Jean-Michel; University of Namur > Namur Nanosafety Centre (NNC), Department of Pharmacy
Evrard, Brigitte ; Université de Liège > Département de pharmacie > Pharmacie galénique
Passirani, Catherine; University of Angers > MINT, INSERM 1066, CNRS 6021
Piel, Géraldine ; Université de Liège > Département de pharmacie > Pharmacie galénique
Language :
English
Title :
Development and evaluation of injectable nanosized drug delivery systems for apigenin
Allard, E., Passirani, C., Garcion, E., Pigeon, P., Vessieres, A., Jaouen, G., Benoit, J.P., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas. J. Control. Release 130 (2008), 146–153.
Baeten, E., Vanslambrouck, S., Jérôme, C., Lecomte, P., Junkers, T., Anionic flow polymerizations toward functional polyphosphoesters in microreactors: polymerization and UV-modification. Eur. Polym. J. 80 (2016), 208–218.
Bellavance, M.A., Poirier, M.B., Fortin, D., Uptake and intracellular release kinetics of liposome formulations in glioma cells. Int. J. Pharm. 395 (2010), 251–259.
Cajot, S., Lautram, N., Passirani, C., Jerome, C., Design of reversibly core cross-linked micelles sensitive to reductive environment. J. Control. Release 152 (2011), 30–36.
Capriotti, A.L., Caracciolo, G., Cavaliere, C., Foglia, P., Pozzi, D., Samperi, R., Lagana, A., Do plasma proteins distinguish between liposomes of varying charge density. J. Proteomics 75 (2012), 1924–1932.
Caracciolo, G., Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines. Nanomedicine 11 (2015), 543–557.
Clement, B., Grignard, B., Koole, L., Jérôme, C., Lecomte, P., Metal-free strategies for the synthesis of functional and well-defined polyphosphoesters. Macromolecules 45 (2012), 4476–4486.
De Melo, N.F., De Araujo, D.R., Grillo, R., Moraes, C.M., De Matos, A.P., de Paula, E., Rosa, A.H., Fraceto, L.F., Benzocaine-loaded polymeric nanocapsules: study of the anesthetic activities. J. Pharm. Sci. 101 (2012), 1157–1165.
Eavarone, D.A., Yu, X., Bellamkonda, R.V., Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. J. Biomed. Mater. Res. 51 (2000), 10–14.
Engelmann, C., Blot, E., Panis, Y., Bauer, S., Trochon, V., Nagy, H., Lu, H., Soria, C., Apigenin-strong cytostatic and anti-angiogenic action in vitro contrasted by lack of efficacy in vivo. Phytomedicine 9 (2002), 489–495.
Favaro, G., Clementi, C., Romani, A., Vickackaite, V., Acidichromism and ionochromism of luteolin and apigenin, the main components of the naturally occurring yellow weld: a spectrophotometric and fluorimetric study. J. Fluoresc. 17 (2007), 707–714.
Fotakis, G., Timbrell, J.A., In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 160 (2006), 171–177.
Fu, J.Y., Blatchford, D.R., Tetley, L., Dufes, C., Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles. J. Control. Release 140 (2009), 95–99.
Gao, H., He, Q., The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior. Expert Opin. Drug Deliv. 11 (2014), 409–420.
Gradolatto, A., Canivenc-Lavier, M.C., Basly, J.P., Siess, M.H., Teyssier, C., Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver. Drug Metab. Dispos. 32 (2004), 58–65.
Gradolatto, A., Basly, J.P., Berges, R., Teyssier, C., Chagnon, M.C., Siess, M.H., Canivenc-Lavier, M.C., Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab. Dispos. 33 (2005), 49–54.
He, C., Hu, Y., Yin, L., Tang, C., Yin, C., Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31 (2010), 3657–3666.
Heurtault, B., Saulnier, P., Pech, B., Venier-Julienne, M.-C., Proust, J.-E., Phan-Tan-Luu, R., Benoı̂t, J.-P., The influence of lipid nanocapsule composition on their size distribution. Eur. J. Pharm. Sci. 18 (2003), 55–61.
Holder, A.L., Goth-Goldstein, R., Lucas, D., Koshland, C.P., Particle-induced artifacts in the MTT and LDH viability assays. Chem. Res. Toxicol. 25 (2012), 1885–1892.
Iyer, A.K., Khaled, G., Fang, J., Maeda, H., Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11 (2006), 812–818.
Jeon, S.I., Lee, J.H., Andrade, J.D., De Gennes, P.G., Protein–surface interactions in the presence of polyethylene oxide. J. Colloid Interface Sci. 142 (1991), 149–158.
Karim, R., Palazzo, C., Evrard, B., Piel, G., Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art. J. Control. Release 227 (2016), 23–37.
Karim, R., Somani, S., Al Robaian, M., Mullin, M., Amor, R., McConnell, G., Dufes, C., Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E α-tocotrienol. J. Control. Release 246 (2017), 79–87.
Kroll, A., Pillukat, M.H., Hahn, D., Schnekenburger, J., Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur. J. Pharm. Biopharm. 72 (2009), 370–377.
Lainé A.-L., Clavreul, A., Rousseau, A., Tétaud, C., Vessieres, A., Garcion, E., Jaouen, G., Aubert, L., Guilbert, M., Benoit, J.-P., Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules. Nanomedicine 10 (2014), 1667–1677.
Laine, A.L., Gravier, J., Henry, M., Sancey, L., Bejaud, J., Pancani, E., Wiber, M., Texier, I., Coll, J.L., Benoit, J.P., Passirani, C., Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring. J. Control. Release 188 (2014), 1–8.
Lamprecht, A., Bouligand, Y., Benoit, J.P., New lipid nanocapsules exhibit sustained release properties for amiodarone. J. Control. Release 84 (2002), 59–68.
Lappalainen, K., Jaaskelainen, I., Syrjanen, K., Urtti, A., Syrjanen, S., Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm. Res. 11 (1994), 1127–1131.
Lee, J.H., Zhou, H.Y., Cho, S.Y., Kim, Y.S., Lee, Y.S., Jeong, C.S., Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Arch. Pharm. Res. 30 (2007), 1318–1327.
Li, B., Robinson, D.H., Birt, D.F., Evaluation of properties of apigenin and [G-3H]apigenin and analytic method development. J. Pharm. Sci. 86 (1997), 721–725.
Li, F., Zhao, X., Wang, H., Zhao, R., Ji, T., Ren, H., Anderson, G.J., Nie, G., Hao, J., Multiple layer-by-layer lipid-polymer hybrid nanoparticles for improved FOLFIRINOX chemotherapy in pancreatic tumor models. Adv. Funct. Mater. 25 (2015), 788–798.
Lim, L.Y., Koh, P.Y., Somani, S., Al Robaian, M., Karim, R., Yean, Y.L., Mitchell, J., Tate, R.J., Edrada-Ebel, R., Blatchford, D.R., Mullin, M., Dufes, C., Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes. Nanomedicine 11 (2015), 1445–1454.
Lobner, D., Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J. Neurosci. Methods 96 (2000), 147–152.
Lopalco, A., Ali, H., Denora, N., Rytting, E., Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast. Int. J. Nanomed. 10 (2015), 1985–1996.
Lv, H., Zhang, S., Wang, B., Cui, S., Yan, J., Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114 (2006), 100–109.
Meerasa, A.G., Huang, J.X., Gu, F., CH50: A revisited hemolytic complement consumption assay for evaluation of nanoparticles and blood plasma protein interaction. Curr. Drug Deliv. 8 (2011), 290–298.
Moore, T.L., Rodriguez-Lorenzo, L., Hirsch, V., Balog, S., Urban, D., Jud, C., Rothen-Rutishauser, B., Lattuada, M., Petri-Fink, A., Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem. Soc. Rev. 44 (2015), 6287–6305.
Mora-Huertas, C.E., Fessi, H., Elaissari, A., Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 385 (2010), 113–142.
Mora-Huertas, C.E., Garrigues, O., Fessi, H., Elaissari, A., Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: comparative study. Eur. J. Pharm. Biopharm. 80 (2012), 235–239.
Mosqueira, V.C., Legrand, P., Morgat, J.L., Vert, M., Mysiakine, E., Gref, R., Devissaguet, J.P., Barratt, G., Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm. Res. 18 (2001), 1411–1419.
Nag, O.K., Awasthi, V., Surface engineering of liposomes for stealth behavior. Pharmaceutics 5 (2013), 542–569.
Nag, O.K., Yadav, V.R., Hedrick, A., Awasthi, V., Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo. Int. J. Pharm. 446 (2013), 119–129.
Nel, A.E., Madler, L., Velegol, D., Xia, T., Hoek, E.M., Somasundaran, P., Klaessig, F., Castranova, V., Thompson, M., Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8 (2009), 543–557.
Palchetti, S., Colapicchioni, V., Digiacomo, L., Caracciolo, G., Pozzi, D., Capriotti, A.L., La Barbera, G., Lagana, A., The protein corona of circulating PEGylated liposomes. Biochim. Biophys. Acta 1858 (2016), 189–196.
Papay, Z.E., Sebestyen, Z., Ludanyi, K., Kallai, N., Balogh, E., Kosa, A., Somavarapu, S., Boddi, B., Antal, I., Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin. J. Pharm. Biomed. Anal. 117 (2016), 210–216.
Patel, D., Shukla, S., Gupta, S., Apigenin and cancer chemoprevention: progress, potential and promise (review). Int. J. Oncol. 30 (2007), 233–245.
Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
Rabanel, J.M., Hildgen, P., Banquy, X., Assessment of PEG on polymeric particles surface, a key step in drug carrier translation. J. Control. Release 185 (2014), 71–87.
Romanova, D., Vachalkova, A., Cipak, L., Ovesna, Z., Rauko, P., Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Neoplasma 48 (2001), 104–107.
Senior, J., Crawley, J.C., Gregoriadis, G., Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim. Biophys. Acta 839 (1985), 1–8.
Sharma, A., Sharma, U.S., Straubinger, R.M., Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia. Cancer Lett. 107 (1996), 265–272.
Shukla, S., Gupta, S., Apigenin: a promising molecule for cancer prevention. Pharm. Res. 27 (2010), 962–978.
Straubinger, R.M., Sharma, A., Murray, M., Mayhew, E., Novel taxol formulations: taxol-containing liposomes. J. Natl. Cancer Inst., 1993, 69–78.
Tripodo, G., Pasut, G., Trapani, A., Mero, A., Lasorsa, F.M., Chlapanidas, T., Trapani, G., Mandracchia, D., Inulin-D-alpha-tocopherol succinate (INVITE) nanomicelles as a platform for effective intravenous administration of curcumin. Biomacromolecules 16 (2015), 550–557.
Tungjai, M., Poompimon, W., Loetchutinat, C., Kothan, S., Dechsupa, N., Mankhetkorn, S., Spectrophotometric characterization of behavior and the predominant species of flavonoids in physiological buffer: determination of solubility, lipophilicity and anticancer efficacy. Open Drug Deliv. J. 2 (2008), 10–19.
Vanslambrouck, S., Polyphosphate-based Amphiphilic Copolymers: Synthesis and Application to Drug Nanocarriers. 2015, University of Liège, Liège, Belgium.
Vonarbourg, A., Passirani, C., Saulnier, P., Simard, P., Leroux, J.C., Benoit, J.P., Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J. Biomed. Mater. Res. 78 (2006), 620–628.
Wan, L., Guo, C., Yu, Q., Li, Y., Wang, X., Wang, X., Chen, C., Quantitative determination of apigenin and its metabolism in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry. J. Chromatogr. B 855 (2007), 286–289.
Wang, P., Henning, S.M., Heber, D., Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One, 5, 2010, e10202.
Watnasirichaikul, S., Rades, T., Tucker, I.G., Davies, N.M., Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions. Int. J. Pharm. 235 (2002), 237–246.
Wei, X., Gao, J., Zhan, C., Xie, C., Chai, Z., Ran, D., Ying, M., Zheng, P., Lu, W., Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. J. Control. Release 218 (2015), 13–21.
Wolfram, J., Suri, K., Yang, Y., Shen, J., Celia, C., Fresta, M., Zhao, Y., Shen, H., Ferrari, M., Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids Surf. B Biointerfaces 114 (2014), 294–300.
Xu, X., Yu, L., Chen, G., Determination of flavonoids in Portulaca oleracea L by capillary electrophoresis with electrochemical detection. J. Pharm. Biomed. Anal. 41 (2006), 493–499.
Yilmaz, Z.E., Jerome, C., Polyphosphoesters: new trends in synthesis and drug delivery applications. Macromol. Biosci. 16 (2016), 1745–1761.
Yilmaz, Z.E., Vanslambrouck, S., Cajot, S., Thiry, J., Debuigne, A., Lecomte, P., Jérôme, C., Riva, R., Core cross-linked micelles of polyphosphoester containing amphiphilic block copolymers as drug nanocarriers. RSC Adv. 6 (2016), 42081–42088.
Yuan, J.-L., Liu, Z.-G., Hu, Z., Zou, G.-L., Study on interaction between apigenin and human serum albumin by spectroscopy and molecular modeling. J. Photochem. Photobiol. A: Chem. 191 (2007), 104–113.
Zanotto-Filho, A., Coradini, K., Braganhol, E., Schroder, R., de Oliveira, C.M., Simoes-Pires, A., Battastini, A.M., Pohlmann, A.R., Guterres, S.S., Forcelini, C.M., Beck, R.C., Moreira, J.C., Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur. J. Pharm. Biopharm. 83 (2013), 156–167.
Zhang, J., Liu, D., Huang, Y., Gao, Y., Qian, S., Biopharmaceutics classification and intestinal absorption study of apigenin. Int. J. Pharm. 436 (2012), 311–317.
Zhang, J., Huang, Y., Liu, D., Gao, Y., Qian, S., Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur. J. Pharm. Sci. 48 (2013), 740–747.
Zhao, L., Zhang, L., Meng, L., Wang, J., Zhai, G., Design and evaluation of a self-microemulsifying drug delivery system for apigenin. Drug Dev. Ind. Pharm. 39 (2013), 662–669.
Zheng, P.-W., Chiang, L.-C., Lin, C.-C., Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci. 76 (2005), 1367–1379.
